Oncophage

Related by string. * * vaccine Oncophage . tumor Oncophage . Oncophage vaccination . Oncophage vitespen *

Related by context. All words. (Click for frequent words.) 64 ADVEXIN 64 BiovaxID 63 Vectibix 62 panitumumab 62 Jevtana 62 maribavir 62 OPAXIO 62 Genasense 62 Amrubicin 61 Advexin 61 Ceplene 61 TEMODAL 61 vandetanib 60 axitinib 60 L MTP PE 60 GVAX 60 valopicitabine 60 Orathecin 60 satraplatin 60 ASA# 60 T DM1 60 DCVax Brain 59 Folotyn 59 Clolar 59 oral ridaforolimus 59 Erbitux 59 Reolysin 59 TREANDA 59 FOLOTYN 59 Tavocept 59 TELCYTA 59 pixantrone 59 Stimuvax 59 aflibercept 59 picoplatin 59 EFAPROXYN 58 TORISEL 58 Diamyd ® 58 Targretin 58 ipilimumab 58 FavId 58 ERBITUX 58 vaccine Oncophage 58 Allovectin 7 ® 58 DCVax R Brain 58 MOZOBIL 58 carfilzomib 58 TroVax 58 Proxinium TM 58 Xgeva 58 ambrisentan 58 MAGE A3 ASCI 58 tanespimycin 58 Cladribine Tablets 58 Specifid 58 Nexavar 58 Civacir 58 Ceflatonin 58 Azedra 58 Treanda 57 SEBIVO 57 Evoltra 57 Erbitux cetuximab 57 Actemra 57 Canvaxin 57 clofarabine 57 PROSTVAC TM 57 Evoltra TM 57 Mylotarg 57 ruxolitinib 57 OvaRex ® MAb 57 Certican 57 mapatumumab 57 MEPACT 57 Junovan 57 Allovectin 7 R 57 BENLYSTA 57 Combidex 57 Kynapid 57 Dacogen 57 tesmilifene 57 YONDELIS 57 perifosine 57 ixabepilone 57 Marqibo 57 phase IIa clinical 57 nimotuzumab 57 phase IIb clinical 57 vemurafenib 57 Vidaza 57 HuMax CD4 57 Velcade bortezomib 57 Dacogen injection 57 Asentar 57 Allovectin 7 57 tivozanib 57 Ventavis 57 VIDAZA 57 Multikine 57 metastatic renal cell carcinoma 57 ImClone Erbitux 57 dalbavancin 57 Hycamtin 57 Celgene Revlimid 57 Urocidin 57 Viramidine 56 Vasovist 56 sipuleucel T 56 adecatumumab 56 RSR# 56 Panitumumab 56 romiplostim 56 Removab 56 Mozobil 56 Campath ® 56 PROVENGE 56 Abraxane 56 metastatic colorectal cancer 56 EOquin 56 tamibarotene 56 lintuzumab 56 Virulizin R 56 Loramyc ® 56 BAY #-# 56 CoFactor 56 OncoVEX 56 Loramyc R 56 tafamidis 56 MyVax 56 blinatumomab 56 lumiliximab 56 ZEVALIN 56 mRCC 56 Pirfenidone 56 Fodosine 56 Zadaxin 56 Ranexa 56 GRN# 56 ELACYT 56 IMGN# 56 pralatrexate 56 trastuzumab DM1 T DM1 56 mertansine 56 Phenoptin 56 Nexavar sorafenib 56 XGEVA 56 Phase IIIb clinical 56 pazopanib 56 StemEx R 56 PSMA ADC 56 omacetaxine 56 adjuvant colon cancer 56 MYDICAR 56 Tarceva TM 55 PrevOnco 55 BLP# Liposome Vaccine 55 Movectro 55 TRISENOX 55 TheraCIM 55 ONTAK 55 Medicinal Products EMEA 55 fidaxomicin 55 Cimzia 55 TNFerade 55 pradefovir 55 BEXXAR 55 enzastaurin 55 Increlex R 55 temsirolimus 55 Rhucin ® 55 Insegia 55 refractory Hodgkin lymphoma 55 IRESSA 55 StaphVAX 55 zalutumumab 55 Torisel 55 Cubicin 55 TAXUS Element Stent System 55 supplemental biologics 55 Vitaxin 55 Xyotax 55 HuMax CD# 55 obatoclax 55 sapacitabine 55 Clolar ® 55 Satraplatin 55 glufosfamide 55 infusional 5-FU/LV 55 elacytarabine 55 OncoVEX GM CSF 55 amrubicin 55 INTERCEPT platelets 55 azacitidine 55 Onrigin 55 SCCHN 55 ZACTIMA 55 SinuNase 55 IRX 2 55 G#DT 55 daclizumab 55 Evoltra ® 55 radiation sensitizer 55 OncoVex 55 teriflunomide 55 Tamibarotene 55 Fludara 55 ridaforolimus 55 Alocrest 55 Marketing Authorization Application 55 Kepivance 55 ATryn R 55 refractory APL 55 cancer immunotherapies 55 bardoxolone 55 Gliadel Wafer 55 metastatic melanoma 55 Zevalin 55 Bronchitol 55 metastatic CRC 55 Prochymal 55 L BLP# 55 Vectibix panitumumab 55 TroVax ® 55 Synvisc One 55 ganetespib 55 orphan designation 55 Sebivo 54 Zactima 54 darapladib 54 MabThera Rituxan 54 dacetuzumab 54 Afinitor 54 telbivudine 54 MyVax R 54 Stimuvax R 54 GALNS 54 Theratope 54 Arranon 54 ATryn ® 54 Nexavar ® 54 iclaprim 54 Plenaxis R 54 telaprevir 54 mifamurtide 54 T Pred 54 Arzerra 54 TYSABRI 54 BRIM2 54 IMA# 54 SNT MC# 54 Pixantrone 54 Targretin capsules 54 NEUPOGEN 54 BRAF inhibitor 54 ofatumumab 54 Rituxan 54 EOquin TM 54 motavizumab 54 Zerenex 54 cediranib 54 ocrelizumab 54 pirfenidone 54 rhThrombin 54 Cotara 54 Fibrin Pad 54 Icatibant 54 PROMACTA 54 B CLL 54 MGd 54 cabazitaxel 54 apaziquone 54 Arzerra ofatumumab 54 EndoTAG TM -1 54 refractory angina 54 YERVOY 54 Novartis Zometa 54 Soliris 54 registrational 54 Pegintron 54 Firazyr 54 HEPLISAV 54 TYZEKA 54 sunitinib 54 Pixuvri 54 ZYBRESTAT 54 Ceplene TM 54 Cimzia ® 54 Pfizer Sutent 54 indolent NHL 54 ILLUMINATE 54 Herceptin trastuzumab 54 Revlimid 54 FTY# 54 Taxotere R 54 methylnaltrexone 54 LymphoStat B 54 gastrointestinal stromal tumors 54 Tarceva erlotinib 54 UVIDEM 54 NEUMUNE 54 Rituxan rituximab 54 Corlux 54 Xelox 54 adult chronic ITP 54 elotuzumab 54 CD# antibody [001] 54 M Vax 54 Dendreon Provenge 54 ELIQUIS 54 Rhucin 54 clevudine 54 custirsen 54 StemEx 54 eniluracil 54 Mepact 54 decitabine 54 PROSTVAC ® 54 Archexin 54 APTIVUS R 54 Gemzar 54 Aplidin 54 ponatinib 54 pomalidomide 54 Hematide 54 Onbrez Breezhaler 53 MabCampath 53 talactoferrin 53 belinostat 53 trabectedin 53 Cimzia ® certolizumab pegol 53 Nplate 53 Virulizin ® 53 Avastin bevacizumab 53 Neuvenge 53 orphan medicinal product 53 Fludara ® 53 Increlex TM 53 Amigal 53 Phase Ib II 53 SIR Spheres 53 sBLA 53 MAXY G# 53 TYKERB 53 Neuradiab 53 cilengitide 53 Hexvix 53 Antegren 53 HGS ETR1 53 Romiplostim 53 PrevOnco ™ 53 Mycograb 53 RoACTEMRA 53 Provenge 53 vismodegib 53 IMC #B 53 XELOX 53 Naglazyme 53 R sorafenib tablets 53 Yondelis ® 53 relapsed refractory multiple myeloma 53 subcutaneous formulation 53 Loramyc 53 sorafenib tablets 53 SUTENT 53 Leukine 53 iniparib 53 recurrent NSCLC 53 Taxotere docetaxel 53 OHR/AVR# 53 Cethrin 53 Raptiva R 53 Revlimid lenalidomide 53 canakinumab 53 CONBRIZA 53 palifermin 53 Zirgan 53 ACZ# 53 BioNumerik 53 relapsed multiple myeloma 53 IIa trial 53 Betaferon ® 53 zanolimumab 53 pegylated interferon alfa 2b 53 alvespimycin 53 liver metastases 53 Onco TCS 53 rilonacept 53 PEG INTRON 53 ROTATEQ 53 Entereg 53 Raptiva ® 53 ZOLINZA 53 Heplisav 53 Centralized Procedure 53 Vandetanib 53 velaglucerase alfa 53 randomized multicenter Phase III 53 Hectorol 53 tremelimumab 53 ONGLYZA ™ 53 REOLYSIN ® 53 recurrent GBM 53 REBETOL combination therapy 53 Oncaspar 53 Ilaris 53 RhuDex ® 53 Phase IIa clinical 53 refractory acute myeloid 53 Bezielle 53 figitumumab 53 Bonefos 53 DCVax 53 PREOS 53 Telcyta 53 XmAb# 53 vorinostat 53 Arixtra 53 pivotal Phase III 53 metastatic GIST 53 Somatuline Depot 53 UPLYSO 53 Reclast Aclasta 53 CAELYX 53 Campath alemtuzumab 53 Ontak 53 Rhucin R 53 Voraxaze 53 Tyvaso 53 Pivotal Phase III 53 ONCASPAR 53 PXD# 53 Femara 53 plus dexamethasone 53 Hepatocellular Carcinoma HCC 53 Neulasta ® 53 Kuvan 53 Soliris TM eculizumab 53 ceftaroline 53 pegfilgrastim 53 Phase #b/#a 53 Avastin 53 Ziopharm 53 cinacalcet HCl 53 taliglucerase alfa 53 Traficet EN 53 INCB# [001] 53 rindopepimut 53 Riquent 53 Taxotere ® 53 SAR# [004] 53 NOXAFIL 53 Engerix B 53 Evoltra R 53 vinflunine 53 neratinib 53 Taxus Liberte 53 HRPC 53 BARACLUDE R 53 Taxotere chemotherapy 52 Genentech Roche 52 Vicinium TM 52 Bayer Nexavar 52 motesanib 52 VPRIV 52 terlipressin 52 Gleevec Glivec 52 Biologics License Application 52 CBLC# 52 Ambrisentan 52 Zalbin 52 dirucotide 52 PRECISE trial 52 DPX Survivac 52 mCRC 52 prGCD 52 biologic therapy 52 Extavia 52 mipomersen 52 GVAX immunotherapy 52 levosimendan 52 Zolinza 52 Exelixis XL# 52 Cetrorelix 52 Tarceva 52 LEUKINE 52 Phase #b/#a clinical 52 Aryplase 52 AQ4N 52 tesetaxel 52 ZADAXIN 52 Genasense ® 52 voclosporin 52 Panzem 52 INCB# [002] 52 eltrombopag 52 thymalfasin 52 alvimopan 52 low dose cytarabine 52 CHMP recommendation 52 Tekturna HCT 52 sunitinib malate 52 pertuzumab 52 phase IIb trial 52 Gemzar ® 52 Azixa 52 Imprime PGG 52 tolevamer 52 Privigen 52 Curaxin CBLC# 52 JAK inhibitor 52 MAA submission 52 multicenter Phase 52 Degarelix 52 EGFR expressing mCRC 52 myelodysplastic syndromes 52 TBC# 52 Aptivus ® 52 Mycamine 52 bosutinib 52 Advagraf 52 lupus nephritis 52 Provenge prostate cancer 52 Peginterferon alfa 2b 52 Cimzia R 52 Delcath PHP System 52 docetaxel Taxotere ® 52 BRIM3 52 calcineurin inhibitors 52 DCVax ® Brain 52 eribulin mesylate 52 GRNVAC1 52 BEMA Fentanyl 52 nonsmall cell lung cancer 52 CR# vcMMAE 52 bevacizumab Avastin 52 NP2 Enkephalin 52 #D#C# 52 Pemetrexed 52 Phase Ib study 52 CYT# 52 PhosLo 52 ZADAXIN ® 52 Cinryze 52 refractory chronic lymphocytic 52 Uplyso 52 Pralatrexate 52 Actimmune ® 52 Bendamustine 52 BrachySil 52 Renvela 52 Tovaxin 52 Pradefovir 52 Tykerb 52 palonosetron 52 AP# [003] 52 anidulafungin 52 Plenaxis 52 Gencaro 52 rituximab Rituxan 52 Betaferon 52 Tyverb 52 lymphoma CTCL 52 Alvesco R 52 Eloxatin ® 52 MGCD# [001] 52 Fusilev 52 NSCLC 52 trastuzumab DM1 52 Reverset 52 Æterna Zentaris 52 PEG interferon 52 Aphthasol R 52 Nebido 52 ACTEMRA 52 Xyrem ® 52 orBec 52 AVADO 52 cladribine 52 rNAPc2 52 phase IIb 52 Vernakalant 52 Albuferon 52 Teysuno 52 Dapagliflozin 52 Increlex 52 Acetavance 52 ENTEREG 52 Panzem R NCD 52 Marketing Authorisation Application 52 BLA submission 52 otelixizumab 52 evaluating REVLIMID 52 amifampridine phosphate 52 Zybrestat 52 Omigard 52 FIRMAGON R 52 Tasigna 52 evaluable patients 52 PROVENGE ® 52 Soliris eculizumab 52 Eribulin 52 refractory multiple myeloma 52 Exherin TM 52 Ocrelizumab 52 anticancer therapy 52 Phase 2b trial 52 Onconase 52 Cloretazine ® 52 AGGRASTAT ® 52 Zelrix 52 ISEL 52 Angiox 52 eprodisate KIACTA TM 52 Onalta 52 Ceflatonin R 52 Noxafil 52 PI3K/Akt pathway inhibitor 52 Evicel 52 Replagal 51 anti EGFR antibody 51 tofacitinib 51 VELCADE 51 dose cohort 51 Tygacil 51 Rasilez Tekturna 51 Gleevec imatinib mesylate 51 bafetinib 51 Cellegesic 51 Troxatyl 51 defibrotide 51 OMP designation 51 Alemtuzumab 51 Orphan Drug designation 51 BrachySil TM 51 HuLuc# 51 Votrient 51 Phase 2b clinical 51 acyclovir Lauriad R 51 Eligard 51 ZALBIN 51 Avelox 51 bendamustine 51 gastrointestinal stromal tumors GIST 51 Ceftobiprole 51 Genentech Rituxan 51 Temodar ® 51 HCD# [002] 51 OMAPRO 51 Increlex ® 51 Quinamed 51 Junovan TM 51 peginesatide 51 sorafenib 51 Cloretazine 51 alemtuzumab Campath 51 HGS ETR2 51 clinical trials 51 Phase III clinical 51 Sprycel 51 Tocosol Paclitaxel 51 Tracleer 51 Ereska 51 DASISION 51 MabThera 51 randomized Phase 51 Aflibercept 51 Yervoy 51 interferon beta 1b 51 vosaroxin 51 Cladribine 51 Vibativ 51 Retacrit 51 BYDUREON 51 sorafenib Nexavar 51 Xcytrin 51 Sutent sunitinib 51 ustekinumab 51 bazedoxifene 51 vernakalant 51 RoActemra 51 CIMZIA TM 51 Multaq R 51 severe hypercholesterolemia 51 OXi# 51 Sym# 51 MKC# PP 51 Xiaflex 51 ozarelix 51 anti CD# antibodies 51 metastatic renal cell 51 monoclonal antibody therapies 51 HER2 positive metastatic breast 51 Orphan Medicinal Product 51 pegloticase 51 Trastuzumab 51 FOLOTYN ® 51 Acapodene 51 Esbriet 51 DCVax ® 51 denosumab 51 glatiramer acetate 51 VEGF Trap 51 daptomycin 51 AEG# 51 PROCHYMAL 51 Prestara 51 Nanobody 51 Golimumab 51 darbepoetin alfa Aranesp 51 Xcellerated T Cells 51 XL# [003] 51 MoxDuo IR 51 deforolimus 51 registrational trial 51 tecarfarin 51 LBH# 51 ARCOXIA 51 Pazopanib 51 Neulasta 51 BCIRG 51 Aclasta 51 Rituxan MabThera 51 Phase III trials 51 ongoing Phase 1b 51 Azilect ® 51 regorafenib 51 Cinryze ™ 51 Yondelis 51 cetuximab Erbitux 51 lorvotuzumab mertansine 51 Firdapse 51 AVASTIN 51 brentuximab vedotin 51 NEBIDO 51 Santhera 51 KRAS mutation 51 cangrelor 51 Fibrillex TM 51 hepatitis C HCV 51 Numax 51 orphan drug 51 bicifadine 51 Biologics License Application BLA 51 orBec R 51 Orphan Drug designations 51 Vertex telaprevir 51 myelodysplastic syndromes MDS 51 OZURDEX ® 51 paliperidone ER 51 ceftobiprole 51 Cinryze TM 51 Nuvion 51 topical NSAID 51 carboplatin paclitaxel 51 ATG Fresenius S 51 Argatroban 51 RG# [001] 51 oxymorphone ER 51 recurrent glioblastoma multiforme 51 EGRIFTA TM 51 OvaRex R 51 Exforge 51 Ixempra 51 IMC A# 51 PREOS R 51 OncoGel 51 Omacetaxine 51 Advaxis Phase 51 voreloxin 51 regadenoson 51 gemcitabine chemotherapy 51 casopitant 51 Tolamba 51 Zingo TM 51 HGS# 51 TOCOSOL Paclitaxel 51 ANTEGREN 51 dasatinib 51 TRISENOX ® 51 Ethyol 51 Nimotuzumab 51 dacarbazine chemotherapy 51 Trofex 51 Promacta 51 European Medicines Evaluation 51 Orencia abatacept 51 Catena ® 51 Natalizumab 51 PDX pralatrexate 51 oral fludarabine 51 Factor VIIa 51 Phase #/#a trial 51 Phase IIb clinical 51 samalizumab 51 THALOMID 51 galiximab 51 PLX PAD 51 STELARA 51 brentuximab 51 Glybera R 51 INTELENCE 51 Phase IIb clinical trials 51 DIFICID 51 Proleukin 51 Thalomid ® 51 efalizumab 51 GATTEX 51 AzaSite 51 monotherapy 51 Novartis Afinitor 51 Dynepo 51 Alkeran 51 naproxcinod 51 tocilizumab 51 Phase Ib clinical 51 Brilique 50 relapsed refractory 50 FIRAZYR 50 Sorafenib 50 cancer mCRC 50 ALN RSV# 50 investigational monoclonal antibody 50 AstraZeneca Iressa 50 HuMax EGFr 50 relapsed MM 50 interferon gamma 1b 50 BR.# 50 Glivec 50 vinorelbine 50 PANVAC VF 50 Plicera 50 GSK# [001] 50 silodosin 50 forodesine 50 dose cohorts 50 Neupogen ® 50 MAXY alpha 50 HERmark 50 Onsolis 50 VFEND 50 Amitiza 50 Tofacitinib 50 eprodisate Fibrillex TM 50 Temsirolimus 50 Roche Avastin 50 everolimus 50 RAPTIVA R 50 posaconazole 50 drug figitumumab 50 metastatic malignant melanoma 50 comparator arm 50 Iressa gefitinib 50 GTC recombinant human 50 REVLIMID 50 romidepsin 50 SUCCEED trial 50 Syncria 50 pegylated interferon alpha 50 DAVANAT ® 50 liver resection surgeries 50 investigational therapies 50 Octreolin 50 oral deforolimus 50 Aurexis 50 ABRAXANE ® 50 Rebif ® 50 ALN VSP 50 ProSavin 50 RAV# 50 Campath 50 EndoTAGTM 1 50 ELOXATIN 50 fingolimod 50 Joulferon 50 Relistor 50 Ceplene R 50 KRAS status 50 pitavastatin 50 Ganite R 50 ATPace TM 50 Gattex 50 Feraheme 50 G CSF 50 Fibrillex 50 antibody MT# 50 phase IIa 50 COPAXONE ® 50 confirmatory Phase III 50 ONGLYZA 50 Orphan Drug Designation 50 Orazol 50 AMEVIVE 50 AeroLEF TM 50 GVAX Pancreas Vaccine 50 afatinib 50 Revimmune 50 CANCIDAS 50 oritavancin 50 eculizumab 50 XIAPEX 50 epratuzumab 50 Amgen Vectibix 50 chronic angina 50 Vion Pharmaceuticals 50 midstage clinical 50 ORENCIA R 50 Lilly Gemzar 50 HepaGam B 50 Azacitidine 50 CytoFab 50 docetaxel Taxotere R 50 DAVANAT R 50 dabigatran etexilate 50 Tarvacin 50 oropharyngeal candidiasis 50 Rasilez 50 Zenapax 50 Dasatinib 50 AGGRASTAT R 50 AZILECT ® 50 XYOTAX 50 Phase 1b clinical 50 Halaven 50 Somatuline R Autogel R 50 Fablyn 50 Sutent 50 Anthim 50 Caelyx 50 Egrifta 50 hA# 50 celgosivir 50 Tyzeka 50 Cimzia TM 50 topotecan 50 ZEVALIN ® 50 Daclizumab 50 CDP# 50 Personalized Immunotherapy 50 CRMD# 50 seliciclib 50 oral FTY# 50 antibody MAb 50 Desmoteplase 50 Laquinimod 50 Endeavor stent 50 velafermin 50 clinical trial 50 Rezonic 50 denufosol 50 Auxilium Pharma 50 MabThera rituximab 50 temozolomide 50 Triapine R 50 atacicept 50 Certriad 50 TACI Ig 50 relapsed ovarian cancer 50 superficial bladder cancer 50 MuGard 50 surrogate endpoint 50 oral methylnaltrexone 50 hematological cancers 50 cetuximab 50 Ceplene/IL-2 50 PLX# 50 MVA BN 50 Atiprimod 50 ACTEMRA TM 50 Phase Ib 50 NovoTTF 50 APPRAISE 50 Filgrastim 50 rolapitant 50 ADVEXIN clinical 50 metastatic RCC 50 Phase 1b 50 AA amyloidosis 50 Xigris 50 TAXUS Liberte Stent 50 Zenpep 50 Litx 50 Epoetin alfa 50 Sanvar R 50 apremilast 50 Zometa zoledronic acid 50 Rasagiline 50 Restanza 50 Abstral 50 Roche Xeloda 50 elesclomol 50 natalizumab 50 Roche Actemra 50 platinum refractory 50 YONDELIS R 50 albinterferon alfa 2b 50 Amplimexon 50 tramiprosate 50 Prexige 50 crofelemer

Back to home page